|
Name |
1-Fluorododecane
|
Molecular Formula | C12H25F | |
IUPAC Name* |
1-fluorododecane
|
|
SMILES |
CCCCCCCCCCCCF
|
|
InChI |
InChI=1S/C12H25F/c1-2-3-4-5-6-7-8-9-10-11-12-13/h2-12H2,1H3
|
|
InChIKey |
YHYBNVZCQIDLSQ-UHFFFAOYSA-N
|
|
Synonyms |
1-FLUORODODECANE; 334-68-9; Dodecyl fluoride; Dodecane, 1-fluoro-; n-Dodecyl fluoride; EINECS 206-381-1; BRN 1738884; 1-fluoro-dodecane; 1-fluoranyldodecane; 1-Fluorododecane, 98%; 4-01-00-00500 (Beilstein Handbook Reference); SCHEMBL318325; DTXSID6074706; ZINC2040783; MFCD00013580; AKOS007930497; AS-81226; DB-048416; FT-0607782; A821788; J-019203
|
|
CAS | 334-68-9 | |
PubChem CID | 9548 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 188.32 | ALogp: | 6.2 |
HBD: | 0 | HBA: | 1 |
Rotatable Bonds: | 10 | Lipinski's rule of five: | Rejected |
Polar Surface Area: | 0.0 | Aromatic Rings: | 0 |
Heavy Atoms: | 13 | QED Weighted: | 0.41 |
Caco-2 Permeability: | -4.708 | MDCK Permeability: | 0.00002370 |
Pgp-inhibitor: | 0.003 | Pgp-substrate: | 0.004 |
Human Intestinal Absorption (HIA): | 0.002 | 20% Bioavailability (F20%): | 0.884 |
30% Bioavailability (F30%): | 0.966 |
Blood-Brain-Barrier Penetration (BBB): | 0.367 | Plasma Protein Binding (PPB): | 97.59% |
Volume Distribution (VD): | 3.383 | Fu: | 1.85% |
CYP1A2-inhibitor: | 0.67 | CYP1A2-substrate: | 0.231 |
CYP2C19-inhibitor: | 0.484 | CYP2C19-substrate: | 0.094 |
CYP2C9-inhibitor: | 0.209 | CYP2C9-substrate: | 0.913 |
CYP2D6-inhibitor: | 0.11 | CYP2D6-substrate: | 0.186 |
CYP3A4-inhibitor: | 0.162 | CYP3A4-substrate: | 0.08 |
Clearance (CL): | 5.827 | Half-life (T1/2): | 0.109 |
hERG Blockers: | 0.011 | Human Hepatotoxicity (H-HT): | 0.21 |
Drug-inuced Liver Injury (DILI): | 0.072 | AMES Toxicity: | 0.035 |
Rat Oral Acute Toxicity: | 0.84 | Maximum Recommended Daily Dose: | 0.289 |
Skin Sensitization: | 0.621 | Carcinogencity: | 0.617 |
Eye Corrosion: | 0.983 | Eye Irritation: | 0.99 |
Respiratory Toxicity: | 0.982 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC000739 | 0.860 | D05ATI | 0.615 | ||||
ENC000421 | 0.762 | D0Z5SM | 0.542 | ||||
ENC000276 | 0.762 | D07ILQ | 0.492 | ||||
ENC000330 | 0.757 | D00AOJ | 0.444 | ||||
ENC000422 | 0.711 | D0O1PH | 0.431 | ||||
ENC000475 | 0.711 | D05QNO | 0.417 | ||||
ENC001240 | 0.711 | D00FGR | 0.400 | ||||
ENC000274 | 0.690 | D0Y8DP | 0.393 | ||||
ENC000272 | 0.690 | D0XN8C | 0.371 | ||||
ENC000266 | 0.681 | D0P1RL | 0.350 |